Brind.

Amgen's stock price was impacted by clinical trial disappointments, while Brent crude influenced S&P 500 market movement.

1 report, 1 independent Updated Sep 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen Brent

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Morgan Stanley and Citigroup raised price objectives on Amgen shares, with MarketBeat reporting the consensus rating.Wed 23:05
- Amgen, Vertex, and Incyte shares traded on Nasdaq, and Robert A. Bradway leads Amgen's long-term growth strategy.Wed 22:56
Brent
- RBI raised repo rate and tightened policy amid elevated crude oil prices, weighing on Indian market sentiment.Fri 18:51
- Nvidia fell sharply during Nasdaq session as crude price effects on the rupee and Indian markets were noted.Fri 18:03

Coverage

Newest first; wire copies grouped

Sep 8yahoo.com